Quest diagnostics launches mobile phlebotomy service, enabling convenient at-home specimen collection in the united states

Quest mobile™ has 5,000 trained mobile phlebotomists whose reach will extend to 44 states by the end of 2023 secaucus, n.j. , nov. 9, 2023 /prnewswire/ -- quest diagnostics (nyse: dgx), the nation's leading provider of diagnostic information services, today announced the launch of quest mobile™, which makes it easier and more convenient for patients to have a specimen collected for lab testing nationwide.
DGX Ratings Summary
DGX Quant Ranking